Lincoln Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹701.70(-1.02%)May 20, 2026 15:24:48 PM IST
- NSE
- BSE
- Vol : 62.24 K (NSE + BSE)Last 20 day avg : 289.69 K
Lincoln Pharmaceuticals is trading -1.02% lower at Rs 701.70 as compared to its last closing price. Lincoln Pharmaceuticals has been trading in the price range of 718.85 & 701.70. Lincoln Pharmaceuticals has given 46.78% in this year & 6.09% in the last 5 days. Lincoln Pharmaceuticals has TTM P/E ratio 11.03 as compared to the sector P/E of 25.16.The company posted a net profit of 28.60 Crores in its last quarter.Listed peers of Lincoln Pharmaceuticals include Sun Pharmaceutical Industries (-0.09%), Divi's Laboratories (0.10%), Torrent Pharmaceuticals (0.04%).The Mutual Fund holding in Lincoln Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Lincoln Pharmaceuticals was at 5.20% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 20, 2026, 11:22 PM UTC
- BetaLow volatility0.76Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.25Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation2.75The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,880.50 | -0.09 | 4,51,148.35 | 37.55 | 5.98 | 0.92 | 0.50 |
| Divi's Laboratories | Bullish | 6,920.00 | 0.10 | 1,83,521.07 | 76.58 | 11.22 | 0.47 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,458.90 | 0.04 | 1,50,903.38 | 75.81 | 19.25 | 0.81 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,320.00 | -1.05 | 1,10,169.57 | 19.19 | 3.23 | 0.61 | 2.34 |
| Lupin | Neutral | 2,288.65 | 0.09 | 1,04,640.71 | 32.01 | 6.22 | 0.51 | 11.80 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE405C01035
- BSE Code531633
- NSE CodeLINCOLN
Lincoln Pharmaceuticals is trading at 701.70 as on Wed May 20 2026 09:54:48. This is -1.02% lower as compared to its previous closing price of 708.90.
The market capitalization of Lincoln Pharmaceuticals is 1393.50 Cr as on Wed May 20 2026 09:54:48.
The 52 wk high for Lincoln Pharmaceuticals is 731.50 whereas the 52 wk low is 439.95
Lincoln Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 11.03
- Sector P/E: 25.16
- Dividend Yield: 0.25%
- D/E ratio: -
Lincoln Pharmaceuticals reported a net profit of 82.35 Cr in 2025.
EQUITY QUICK LINKS
Lincoln Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.